Indivior Pharmaceuticals INDV
NASDAQ INDV
$36.59 -0.29 (-0.79%)
At close: Sep 29, 2026 · 4:00 PM EDT

Indivior Pharmaceuticals (INDV) EV to EBIT (2024 - 2026)

Updated

Indivior Pharmaceuticals' (INDV) EV to EBIT stood at 10.97 in Q2 2026, up 80.8% from 6.07 a year earlier and up 3.2% from the prior quarter.

Analysis

Indivior Pharmaceuticals (INDV) EV to EBIT (2024 - 2026) Analysis & Trends

On a TTM basis, Indivior Pharmaceuticals' EV to EBIT came in at 9.04 as of Jun 30, 2026, up 775.4% year-over-year; for FY2025, it was 16.38, down 49.4% from FY2024.

  • Across earlier years, EV to EBIT came in at 32.35 in FY2024 and 6.62 in FY2021.
  • Quarterly EV to EBIT has ranged from 6.07 in Q2 2025 to 32.35 in Q4 2024 over the past five years.
  • Per Business Quant, the preceding three quarters came in at 10.63 (Q1 2026), 16.38 (Q4 2025) and 11.30 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Indivior Pharmaceuticals 4.35 Bn 3.32 Bn 294.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.97
Mar 31, 2026 10.63
Dec 31, 2025 16.38
Sep 30, 2025 11.30
Jun 30, 2025 6.07
Mar 31, 2025 28.14
Dec 31, 2024 32.35
API Access

Indivior Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=INDV&period=max&api_key=YOUR_API_KEY